✦ LIBER ✦
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer
✍ Scribed by Hurvitz, Sara A; Bosserman, Linda D; Chan, David; Hagenstad, Christopher T; Kass, Frederick C; Smith, Frederick P; Rodriguez, Gladys I; Childs, Barrett H; Slamon, Dennis J
- Book ID
- 125405369
- Publisher
- Springer
- Year
- 2014
- Tongue
- English
- Weight
- 225 KB
- Volume
- 3
- Category
- Article
- ISSN
- 2193-1801
No coin nor oath required. For personal study only.